Gecolin (recombinant HPV type 6/11 bivalent vaccine)
/ Wantai BioPharm
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 15, 2023
Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine
(clinicaltrials.gov)
- P2 | N=640 | Active, not recruiting | Sponsor: Jun Zhang | Trial completion date: Dec 2022 ➔ Dec 2023 | Trial primary completion date: Dec 2022 ➔ Dec 2023
Trial completion date • Trial primary completion date • Oncology
1 to 1
Of
1
Go to page
1